Clinical Trials Directory

Trials / Completed

CompletedNCT02727725

An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images

Establishing the Clinical Usefulness Of Dark Blood Late Gadolinium Enhancement Images For The Detection Of Small Subendocardial Left Ventricular Infarcts - An Evaluation Of The Novel TRAMINER Sequence By Comparison To Late Gadolinium Enhancement Images

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

* The purpose of this study is to show that the novel TRAMINER (T(Rho) and Magnetization Transfer and Inversion Recovery) sequence provides at least as good visualization and detection of sub-endocardial scarring, fibrosis, and acute infarction as the current gold standard Inversion Recovery (IR) Turbo-Flash sequence. * The hypothesis is that the TRAMINER sequence has the same or higher sensitivity in detecting small sub-endocardial scarring than the inversion recovery segmented gradient echo sequence known as IR-Turbo Fast low angle shot (IR Turbo-Flash), which is the accepted current gold standard for the detection of myocardial viability.

Conditions

Interventions

TypeNameDescription
OTHERTraminer MRI SequenceThe Traminer MRI sequence will be added to the standard IR Turbo-Flash sequence and last 2-5 minutes.

Timeline

Start date
2016-01-15
Primary completion
2018-01-15
Completion
2018-01-15
First posted
2016-04-05
Last updated
2024-10-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02727725. Inclusion in this directory is not an endorsement.